9-136431801-T-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_019892.6(INPP5E):​c.1549+23A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.29 ( 1901 hom., cov: 4)
Exomes 𝑓: 0.19 ( 14310 hom. )
Failed GnomAD Quality Control

Consequence

INPP5E
NM_019892.6 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -2.60

Publications

10 publications found
Variant links:
Genes affected
INPP5E (HGNC:21474): (inositol polyphosphate-5-phosphatase E) The protein encoded by this gene is an inositol 1,4,5-trisphosphate (InsP3) 5-phosphatase. InsP3 5-phosphatases hydrolyze Ins(1,4,5)P3, which mobilizes intracellular calcium and acts as a second messenger mediating cell responses to various stimulation. Studies of the mouse counterpart suggest that this protein may hydrolyze phosphatidylinositol 3,4,5-trisphosphate and phosphatidylinositol 3,5-bisphosphate on the cytoplasmic Golgi membrane and thereby regulate Golgi-vesicular trafficking. Mutations in this gene cause Joubert syndrome; a clinically and genetically heterogenous group of disorders characterized by midbrain-hindbrain malformation and various associated ciliopathies that include retinal dystrophy, nephronophthisis, liver fibrosis and polydactyly. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jan 2016]
INPP5E Gene-Disease associations (from GenCC):
  • Joubert syndrome 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, ClinGen, Labcorp Genetics (formerly Invitae), G2P
  • MORM syndrome
    Inheritance: AR Classification: DEFINITIVE, MODERATE, SUPPORTIVE, LIMITED Submitted by: Ambry Genetics, G2P, Genomics England PanelApp, ClinGen, Orphanet
  • COACH syndrome 1
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Joubert syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Joubert syndrome with ocular defect
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.96).
BP6
Variant 9-136431801-T-C is Benign according to our data. Variant chr9-136431801-T-C is described in ClinVar as Benign. ClinVar VariationId is 261197.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.315 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
INPP5ENM_019892.6 linkc.1549+23A>G intron_variant Intron 7 of 9 ENST00000371712.4 NP_063945.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
INPP5EENST00000371712.4 linkc.1549+23A>G intron_variant Intron 7 of 9 1 NM_019892.6 ENSP00000360777.3
INPP5EENST00000676019.1 linkc.1447+23A>G intron_variant Intron 7 of 9 ENSP00000501984.1

Frequencies

GnomAD3 genomes
AF:
0.294
AC:
12719
AN:
43248
Hom.:
1904
Cov.:
4
show subpopulations
Gnomad AFR
AF:
0.257
Gnomad AMI
AF:
0.407
Gnomad AMR
AF:
0.281
Gnomad ASJ
AF:
0.285
Gnomad EAS
AF:
0.182
Gnomad SAS
AF:
0.227
Gnomad FIN
AF:
0.328
Gnomad MID
AF:
0.391
Gnomad NFE
AF:
0.321
Gnomad OTH
AF:
0.256
GnomAD2 exomes
AF:
0.163
AC:
17607
AN:
107742
AF XY:
0.151
show subpopulations
Gnomad AFR exome
AF:
0.189
Gnomad AMR exome
AF:
0.191
Gnomad ASJ exome
AF:
0.148
Gnomad EAS exome
AF:
0.124
Gnomad FIN exome
AF:
0.130
Gnomad NFE exome
AF:
0.186
Gnomad OTH exome
AF:
0.222
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.194
AC:
123121
AN:
635166
Hom.:
14310
Cov.:
21
AF XY:
0.191
AC XY:
61204
AN XY:
320558
show subpopulations
African (AFR)
AF:
0.169
AC:
2616
AN:
15482
American (AMR)
AF:
0.143
AC:
2729
AN:
19056
Ashkenazi Jewish (ASJ)
AF:
0.233
AC:
2308
AN:
9916
East Asian (EAS)
AF:
0.209
AC:
3194
AN:
15318
South Asian (SAS)
AF:
0.110
AC:
5837
AN:
52966
European-Finnish (FIN)
AF:
0.240
AC:
4642
AN:
19342
Middle Eastern (MID)
AF:
0.115
AC:
267
AN:
2328
European-Non Finnish (NFE)
AF:
0.202
AC:
96228
AN:
475448
Other (OTH)
AF:
0.209
AC:
5300
AN:
25310
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
4246
8493
12739
16986
21232
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2906
5812
8718
11624
14530
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.294
AC:
12717
AN:
43262
Hom.:
1901
Cov.:
4
AF XY:
0.279
AC XY:
5741
AN XY:
20610
show subpopulations
African (AFR)
AF:
0.258
AC:
2714
AN:
10530
American (AMR)
AF:
0.280
AC:
1267
AN:
4520
Ashkenazi Jewish (ASJ)
AF:
0.285
AC:
289
AN:
1014
East Asian (EAS)
AF:
0.180
AC:
256
AN:
1420
South Asian (SAS)
AF:
0.222
AC:
225
AN:
1014
European-Finnish (FIN)
AF:
0.328
AC:
774
AN:
2362
Middle Eastern (MID)
AF:
0.390
AC:
32
AN:
82
European-Non Finnish (NFE)
AF:
0.321
AC:
6924
AN:
21540
Other (OTH)
AF:
0.260
AC:
144
AN:
554
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.532
Heterozygous variant carriers
0
365
731
1096
1462
1827
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
118
236
354
472
590
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.124
Hom.:
70

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jun 26, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.96
CADD
Benign
1.9
DANN
Benign
0.16
PhyloP100
-2.6
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11146014; hg19: chr9-139326253; COSMIC: COSV65496968; COSMIC: COSV65496968; API